Home › Products › Ophthalmology › Ranizurel 0.5mg Injection

Ranizurel 0.5mg Injection

Salt Composition: RANIBIZUMAB

₹9933.00₹18740.63

Inclusive of all taxes

Categories: Ophthalmology

Conditions: Others

Product Introduction

Ranizurel 0.5mg Injection contains the active ingredient Ranibizumab, an anti-neovascularisation agent belonging to the class of vascular endothelial growth factor A (VEGF-A) antagonists. It is used in adults to treat several eye diseases that cause vision impairment. The injection is indicated for wet age-related macular degeneration (AMD), a chronic eye condition characterised by loss of central vision that may affect reading, driving, and daily activities. Ranizurel 0.5mg Injection is also used to treat myopic choroidal neovascularization (mCNV), a complication in near-sighted patients where abnormal blood vessels develop at the back of the eye, and macular edema following retinal vein occlusion, an eye condition resulting from blocked blood flow that leads to blurred and diminished vision. It is additionally indicated for diabetic macular edema, an eye condition caused by diabetes that may result in vision loss, and diabetic retinopathy, which refers to damage to the eyes caused by diabetes.

Do not use Ranizurel Injection if you are allergic to Ranibizumab or other ingredients in this medicine. Do not use this medicine if you have an active infection in or around your eye, or if you are experiencing eye pain or redness. Inform your doctor immediately if you develop symptoms including eye pain or increased discomfort, worsening eye redness, blurred or decreased vision, an increased number of floaters in your vision, or heightened sensitivity to light. Inform your doctor if you have a history of eye conditions or previous eye treatments, or if you have had a stroke before starting this treatment.

Uses

Ranizurel 0.5mg Injection uses for treating several eye diseases causing vision impairment, including, Age-related macular degeneration Macular edema Diabetic macular edema and retinopathy Myopic choroidal neovascularization Retinal vein occlusion

How it works

Ranizurel 0.5mg Injection specifically recognizes and binds to a protein called human vascular endothelial growth factor A (VEGF-A) present in the eye. In excess, VEGF-A causes abnormal blood vessel growth and swelling in the eye, leading to impairment of vision in certain eye diseases. This medicine can block its actions and prevent this abnormal growth and swelling. This injection can help to stabilize and improve your vision.

Side Effects

Ranizurel 0.5mg Injection Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common Pain and swelling in the eye Bleeding in the eye Blurred vision Urinary tract infection Skin rashes Discharge from the eye Serious Tear of the layer in the back of the eye Flashes of light in the eye Temporary loss of sight Clouding of lens Infection of the eyeball

References

  1. Lucentis 10 mg/ml solution for injection - Patient Information Leaflet (PIL) - (emc). www.medicines.org.uk. [Revised Nov 2022] [cited 2023 Jun 9]. Available from: https://www.medicines.org.uk/emc/product/307/pil
  2. Genentech, Inc, Lucentis [ranibizumab injection]. Access.fda.gov. [revised October 2014] [cited 2023 Jun 9]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125156s105lbl.pdf
  3. James E Frampton; Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration; Drugs & Aging; Published on May 2013; Accessed on June 09 2023; https://pubmed.ncbi.nlm.nih.gov/23539234/

Safety Advice

Pregnancy: unsafe Ranizurel 0.5mg Injection should not be used during pregnancy because it may cause risk to the unborn child. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant during the treatment. Use effective contraception during treatment and at least three months after the last dose.

Lungs: Consult your doctor It is unknown whether Ranizurel 0.5mg Injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.

Breastfeeding: unsafe Ranizurel 0.5mg Injection should not be used in breastfeeding women because the medicine passes into the breast milk in small amounts and may harm your baby. Inform your physician if you are breastfeeding.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS